FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
FDA General

Ex-FDA Lawyer Temkin Joins Paul Hastings

Former FDA associate chief counsel and CDER policy advisor Eva A. Temkin joins Paul Hastings as chair of the firms FDA practice.

latest-news-card-1
Medical Devices

Vyaire Recalls Airlife Resuscitator

Vyaire Medical recalls its AirLife Adult Manual Resuscitator and oxygen reservoir bag due to out-of-specification components used in manufacturing.

latest-news-card-1
Human Drugs

Milestone Pharma Refiling Etrpamil NDA

After receiving a 12/2023 FDA refuse-to-file letter, Milestone Pharmaceuticals now says it will resubmit the NDA in the second quarter for etripamil n...

latest-news-card-1
Federal Register

Animal Drug Regs Amended to Reflect Approvals

Federal Register notice: FDA amends its animal drug regulations to reflect application-related actions animal drug applications approved during the fo...

latest-news-card-1
Human Drugs

NY Attorney General Urges FDA Action on Singulair

New York attorney general Letitia James urges FDA to take further safety actions to address the dangers of Mercks Singilair (montelukast) and generics...

latest-news-card-1
Human Drugs

BrainStorm Seeks Special Protocol for ALS Treatment

BrainStorm Cell Therapeutics files a Special Protocol Assessment request for a Phase 3b study of NurOwn, its investigational treatment for amyotrophic...

latest-news-card-1
Human Drugs

Dupixent sBLA Get Priority Review for COPD

FDA accepts for priority review a Sanofi and Regeneron supplemental BLA for Dupixent (dupilumab) as an add-on maintenance treatment in certain adult p...

latest-news-card-1
Human Drugs

Venatorx/Melinta Antibiotic Gets Complete Response

FDA issues Venatorx Pharmaceuticals and Melinta Therapeutics a complete response letter on their NDA for cefepime-taniborbactam, a beta-lactam/beta-la...

latest-news-card-1
Medical Devices

Bioporto Pediatric Kidney Injury Assay Cleared

FDA clears a Bioporto 510(k) for its ProNephro AKI (NGAL) biomarker assay for detecting pediatric acute kidney injury.

latest-news-card-1
Human Drugs

FDA Denies Appeal; Pepaxto to be Withdrawn

FDA rejects an Oncopeptides appeal seeking to stop a CBER request for the company to voluntarily withdraw its accelerated-approved multiple myeloma dr...